Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Atara Biotherapeutics, Inc. (ATRA)

« Back to company index

ATRA Chatter Timeline

Stock Ticker for ATRA

Most Active Tweeters for ATRA

UserTweets
@1MinuteStock 7
@Tickeron 6
@AmericanBanking 4
@ZolmaxNews 4
@WeekHerald 3

Recent Tweets for ATRA

gulfgator33 @gulfgator33
$ATRA Anyone else think @Jefferies is trying a little to hard with multiple comments on ATRA this morning?...I do
12:09pm
AmericanBanking @AmericanBanking
Jefferies Financial Group Downgrades Atara Biotherapeutics $ATRA to Hold https://t.co/xVWq74TlJx #stocks
7:09am
registrarjourn @registrarjourn
Roth Capital Begins Coverage on Atara Biotherapeutics $ATRA https://t.co/yz7MCNXUD8
September 15th 2019, 11:09pm
EnterpriseLeade @EnterpriseLeade
Roth Capital Begins Coverage on Atara Biotherapeutics $ATRA https://t.co/INRUG5RJUJ
September 15th 2019, 11:09pm
ConsumerFeed @ConsumerFeed
Cowen Reiterates “Buy” Rating for Atara Biotherapeutics $ATRA https://t.co/KtpnZErXvQ
September 15th 2019, 11:09pm
AmericanBanking @AmericanBanking
Atara Biotherapeutics $ATRA Receives “Buy” Rating from Cowen https://t.co/WvLwWApKdG #stocks
September 15th 2019, 11:09pm
AmericanBanking @AmericanBanking
Roth Capital Begins Coverage on Atara Biotherapeutics $ATRA https://t.co/OGaiCZ8QYZ #stocks
September 15th 2019, 11:09pm
dispatchtribune @dispatchtribune
Atara Biotherapeutics $ATRA Now Covered by Roth Capital https://t.co/7opKHPaQ6R
September 15th 2019, 11:09pm
WeekHerald @WeekHerald
Atara Biotherapeutics $ATRA Now Covered by Roth Capital https://t.co/xoqIE7AVLm
September 15th 2019, 11:09pm
OlympiaReport @OlympiaReport
Atara Biotherapeutics $ATRA Coverage Initiated by Analysts at Roth Capital https://t.co/h5mvuVJJm7
September 15th 2019, 11:09pm
ZolmaxNews @ZolmaxNews
Atara Biotherapeutics $ATRA Earns Buy Rating from Cowen https://t.co/HrKZipM6t4
September 15th 2019, 11:09pm
OlympiaReport @OlympiaReport
Atara Biotherapeutics $ATRA Stock Rating Reaffirmed by Cowen https://t.co/QLiKlkst7C
September 15th 2019, 11:09pm
WeekHerald @WeekHerald
Atara Biotherapeutics’ $ATRA Buy Rating Reaffirmed at Cowen https://t.co/bvRrGnlJGm
September 15th 2019, 11:09pm
dispatchtribune @dispatchtribune
Atara Biotherapeutics’ $ATRA Buy Rating Reaffirmed at Cowen https://t.co/mJIJHgdLx7
September 15th 2019, 11:09pm
ZolmaxNews @ZolmaxNews
Atara Biotherapeutics $ATRA Earns Buy Rating from Cowen https://t.co/JoOly7c6Jl
September 15th 2019, 10:09pm
RolandoAMoreno @RolandoAMoreno
RT @semodough: MIZHOU $ATRA ECTRIMS abstracts abstract contains first-ever cut of efficacy data (plus updated safety data)for ATRA's allo-M…
September 15th 2019, 7:09pm
Gambiste1 @Gambiste1
RT @Quantumup1: Stifel reiterated a Buy rating ,$36 price target on $ATRA https://t.co/F9eo4tKoTM
September 15th 2019, 7:09am
Gambiste1 @Gambiste1
RT @Quantumup1: Roth Capital maintaines a Buy rating, $30 PT on $ATRA https://t.co/6KObG5Eyey
September 15th 2019, 7:09am
ZolmaxNews @ZolmaxNews
Atara Biotherapeutics $ATRA Earns Buy Rating from Mizuho https://t.co/D6puYcYgUp
September 14th 2019, 7:09pm
bbnsnews @bbnsnews
Atara Biotherapeutics $ATRA Upgraded at BidaskClub https://t.co/S6TaypkggQ
September 14th 2019, 12:09pm
Tickeron @Tickeron
$ATRA's 10-day Moving Average broke below its 50-day Moving Average on April 15, 2019. View odds for this and other… https://t.co/tXcT4bqOSg
September 14th 2019, 12:09am
Quantumup1 @Quantumup1
Roth Capital maintaines a Buy rating, $30 PT on $ATRA https://t.co/6KObG5Eyey
September 13th 2019, 4:09pm
1MinuteStock @1MinuteStock
Recommendation Moderate #SELL for $ATRA with UB rating - 1.68 out of 5. https://t.co/eQvikWV84I
September 13th 2019, 2:09pm
Quantumup1 @Quantumup1
Stifel reiterated a Buy rating ,$36 price target on $ATRA https://t.co/F9eo4tKoTM
September 13th 2019, 1:09pm
WatchlistN @WatchlistN
Atara Biotherapeutics $ATRA Lifted to “Hold” at BidaskClub https://t.co/yY7l1m92hK
September 13th 2019, 11:09am
ZolmaxNews @ZolmaxNews
Atara Biotherapeutics $ATRA Lifted to “Hold” at BidaskClub https://t.co/1BgQmeml9u
September 13th 2019, 11:09am
dailypoliticaln @dailypoliticaln
Atara Biotherapeutics $ATRA Upgraded to “Hold” by BidaskClub https://t.co/rw0sSX7PNV
September 13th 2019, 11:09am
Saba_Capital @Saba_Capital
$ATRA - Atara T-cell therapy shows encouraging action in early-stage MS study https://t.co/wqZLALi1P0
September 13th 2019, 9:09am
Briefingcom @Briefingcom
$ATRA: Atara Biotherapeutics reports early findings of potential efficacy from Phase 1 Study of ATA188 in patients.… https://t.co/y6YUmFPmXH
September 13th 2019, 8:09am
StockNewsWires @StockNewsWires
$ATRA: Atara T-cell therapy shows encouraging action in early-stage MS study: https://t.co/qfxLqt0rkx
September 13th 2019, 8:09am
MarketCurrents @MarketCurrents
$ATRA - Atara T-cell therapy shows encouraging action in early-stage MS study https://t.co/1N1uIKDUHD
September 13th 2019, 8:09am
HottestStockNow @HottestStockNow
$ATRA Reveals Findings from Early-Stage Study Evaluating ATA188 in Patients with Progressive Multiple Sclerosis… https://t.co/cQZr5SyIMx
September 13th 2019, 7:09am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $ATRA for you: 12.38% https://t.co/mmMRvxwNak
September 13th 2019, 7:09am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $ATRA is $34.14 https://t.co/1WaV1lIsim
September 13th 2019, 7:09am
bdailystocks @bdailystocks
$ATRA Reveals findings from early-stage study evaluating ATA188 for the treatment of progressive forms of multiple… https://t.co/yn7edXfxLe
September 13th 2019, 6:09am
ZoZoStockwatch @ZoZoStockwatch
$ATRA: Atara Biotherapeutics Reports Early Findings of Potential Efficacy from Phase 1 Study of ATA188 in Patients… https://t.co/pdGgTxG1AX
September 13th 2019, 6:09am
dailypoliticaln @dailypoliticaln
Atara Biotherapeutics $ATRA Given “Buy” Rating at Mizuho https://t.co/buxgrHP5yS
September 12th 2019, 9:09pm
WatchlistN @WatchlistN
Mizuho Reiterates Buy Rating for Atara Biotherapeutics $ATRA https://t.co/MFQuvA2J1l
September 12th 2019, 9:09pm
TickerReport @TickerReport
BidaskClub Upgrades Atara Biotherapeutics $ATRA to “Hold” https://t.co/SkT7Ym2uNC
September 12th 2019, 11:09am
Tickeron @Tickeron
$ATRA in Downtrend: its price may drop because broke its higher Bollinger Band on September 9, 2019. View odds for… https://t.co/sHcwtJAMUv
September 11th 2019, 10:09pm
macondailynews @macondailynews
Atara Biotherapeutics $ATRA Stock Price Up 2% https://t.co/CnIOzCoWnz
September 11th 2019, 3:09pm
TheMarketsDaily @TheMarketsDaily
Atara Biotherapeutics $ATRA Shares Up 2% https://t.co/c2Qm09Tub3
September 11th 2019, 3:09pm
AmericanBanking @AmericanBanking
Atara Biotherapeutics $ATRA Earns Buy Rating from Mizuho https://t.co/I8ReMoQhwY #stocks
September 11th 2019, 12:09pm
WeekHerald @WeekHerald
Atara Biotherapeutics $ATRA Stock Rating Reaffirmed by Mizuho https://t.co/BRrrZOXjqK
September 11th 2019, 11:09am
semodough @semodough
MIZHOU $ATRA ECTRIMS abstracts abstract contains first-ever cut of efficacy data (plus updated safety data)for ATRA… https://t.co/yt4A9t23RY
September 11th 2019, 9:09am
Tickeron @Tickeron
$ATRA's price moved below its 50-day Moving Average on April 9, 2019. View odds for this and other indicators:… https://t.co/T8lmeuHgky
September 10th 2019, 9:09pm
JDogg_Capital @JDogg_Capital
$ATRA 15c now at 1.80... looking nice here... https://t.co/kXNu9Hei9V
September 10th 2019, 11:09am
Tickeron @Tickeron
$ATRA in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on April 26, 2019. View odds for thi… https://t.co/CGcmL6m20T
September 9th 2019, 10:09pm
dakotafinancial @dakotafinancial
Analysts Set Atara Biotherapeutics Inc $ATRA Price Target at $43.40 https://t.co/0huH89u8te
September 9th 2019, 7:09pm
IlliniJJ @IlliniJJ
$ATRA-today announced it will present for the first time initial efficacy data/updated safety results from its ongo… https://t.co/RFP5e6hBOe
September 9th 2019, 4:09pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.